Focus Partners Wealth Portfolio holdings
AUM
$46.1B
1-Year Return
15.84%
This Quarter Return
+1.32%
1 Year Return
+15.84%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$38.5B
AUM Growth
+$7.12B
(+23%)
Cap. Flow
+$6.27B
Cap. Flow
% of AUM
16.3%
Top 10 Holdings %
Top 10 Hldgs %
22.39%
Holding
1,948
New
393
Increased
1,064
Reduced
325
Closed
97
Top Buys
| 1 |
Apple
AAPL
|
$466M |
| 2 |
Amazon
AMZN
|
$361M |
| 3 |
Microsoft
MSFT
|
$325M |
| 4 |
Alphabet (Google) Class C
GOOG
|
$257M |
| 5 |
iShares Russell 1000 Growth ETF
IWF
|
$212M |
Top Sells
| 1 |
Netflix
NFLX
|
$635M |
| 2 |
Allstate
ALL
|
$221M |
| 3 |
Air Lease Corp
AL
|
$165M |
| 4 |
Global X Lithium & Battery Tech ETF
LIT
|
$144M |
| 5 |
Vanguard Mid-Cap ETF
VO
|
$127M |
Sector Composition
| 1 | Technology | 14.02% |
| 2 | Financials | 7.36% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Communication Services | 4.09% |
| 5 | Healthcare | 4.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Nerdy
NRDY
$161M
| $25.1K | ﹤0.01% |
15,476
+17
| +0.1% | +$28 |
|
1827
Standard BioTools
LAB
$493M
| $24.6K | ﹤0.01% |
14,055
+1,053
| +8% | +$1.84K |
|
|
NKLA
1828
DELISTED
Nikola Corporation Common Stock
NKLA
| $22.2K | ﹤0.01% |
18,680
+259
| +1% | +$308 |
|
1829
Akebia Therapeutics
AKBA
$801M
| $20.7K | ﹤0.01% |
+10,892
| New | +$20.7K |
|
1830
Compass Therapeutics
CMPX
$578M
| $19.7K | ﹤0.01% |
+13,591
| New | +$19.7K |
|
1831
Galectin Therapeutics
GALT
$299M
| $19.7K | ﹤0.01% |
15,251
-1,483
| -9% | -$1.91K |
|
1832
Nine Energy Service
NINE
$28.5M
| $19.4K | ﹤0.01% |
17,315
| – | – |
|
1833
Opendoor
OPEN
$4.39B
| $19.1K | ﹤0.01% |
+11,906
| New | +$19.1K |
|
1834
DarioHealth
DRIO
$24.5M
| $18.9K | ﹤0.01% |
1,202
| – | – |
|
1835
X4 Pharmaceuticals
XFOR
$81.7M
| $18.4K | ﹤0.01% |
+834
| New | +$18.4K |
|
1836
GEE Group
JOB
$20.9M
| $15.5K | ﹤0.01% |
75,084
| – | – |
|
1837
Sangamo Therapeutics
SGMO
$160M
| $15.5K | ﹤0.01% |
+15,200
| New | +$15.5K |
|
1838
Allurion Technologies
ALUR
$16.5M
| $15.1K | ﹤0.01% |
+1,402
| New | +$15.1K |
|
1839
Editas Medicine
EDIT
$227M
| $15K | ﹤0.01% |
+11,789
| New | +$15K |
|
1840
Veru
VERU
$48.3M
| $13.8K | ﹤0.01% |
+2,120
| New | +$13.8K |
|
|
VXRT
1841
DELISTED
Vaxart
VXRT
| $11.7K | ﹤0.01% |
17,650
+7,650
| +77% | +$5.07K |
|
|
URG
1842
Ur-Energy
URG
$565M
| $11.5K | ﹤0.01% |
10,000
| – | – |
|
|
OMGA
1843
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $10.4K | ﹤0.01% |
+14,000
| New | +$10.4K |
|
|
ARBK
1844
Argo Blockchain
ARBK
$17.6M
| $6.67K | ﹤0.01% |
11,800
| – | – |
|
|
VINC
1845
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $2.87K | ﹤0.01% |
+545
| New | +$2.87K |
|
|
VIRX
1846
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $2.25K | ﹤0.01% |
14,000
| – | – |
|
1847
Alcoa
AA
$8.1B
| – | – |
-10,400
| Closed | -$401K |
|
1848
Ambev
ABEV
$34.1B
| – | – |
-17,241
| Closed | -$42.1K |
|
1849
Arbor Realty Trust
ABR
$2.28B
| – | – |
-13,325
| Closed | -$207K |
|
1850
ALPS Clean Energy ETF
ACES
$95.6M
| – | – |
-7,146
| Closed | -$210K |
|